Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928082 · ClinicalTrials.gov registry record · Phase 2
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
A Phase 2 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT01928082 is a Phase 2 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 1 participants.
The verdict
NCT01928082, a Phase 2 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to assess if estrogen replacement normalizes urinary calcium excretion in postmenopausal women with hypercalciuria and low bone mass and to assess for differences in response to estrogen replacement in women with familial hypercalciuria compared to nonfamilial hypercalciuria.
Interventions
- DRUG Transdermal estradiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-08-01 |
| Est. Completion | 2014-08-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01928082
The ClinicalTrials.gov registry entry for NCT01928082 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transdermal estradiol is the first listed.
NCT01928082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01928082 about?
NCT01928082 is a clinical study titled "The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass". The purpose of this study is to assess if estrogen replacement normalizes urinary calcium excretion in postmenopausal women with hypercalciuria and low bone mass and to assess for differences in response to estrogen replacement in women with familial hypercalciuria compared to nonfamilial hypercalci...
What is the current status of trial NCT01928082?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2013-08-01. Estimated completion is 2014-08-01.
What interventions are being tested in trial NCT01928082?
The interventions under investigation include: Transdermal estradiol (DRUG).
Who is sponsoring clinical trial NCT01928082?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.